Intellia Therapeutics, Inc. ( NTLA) - Key Metrics
NTLA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.21 | -$0.88 | -$0.64 | -$0.64 |
| 2025Q3 | $0.13 | -$0.92 | -$0.70 | -$0.70 |
| 2025Q2 | $0.14 | -$0.98 | -$0.96 | -$0.96 |
| 2025Q1 | $0.16 | -$1.10 | -$1.44 | -$1.45 |
NTLA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -2.54 |
| 2025Q3 | ? | -4.70 |
| 2025Q2 | ? | -2.40 |
| 2025Q1 | ? | -1.61 |
NTLA
Price: $10.73
52 week price:
Earnings Per Share: -3.52 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.1 million
Ebitda: -15.1 millionMarket Capitalization: 2.0 billion